Skip to main content

3 Result(s)

within J. KAERN Remove this filter

and
Your search also matched 3 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status

Include preview-only content

  1. Article

    Open Access

    Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

    The CALYPSO phase III trial compared CD (carboplatin-pegylated liposomal doxorubicin (PLD)) with CP (carboplatin-paclitaxel) in patients with platinum-sensitive recurrent ovarian cancer (ROC). Overall survival...

    U Wagner, C Marth, R Largillier, J Kaern, C Brown, M Heywood… in British Journal of Cancer (2012)

    Download PDF (219 KB) View Article

  2. Article

    Open Access

    Human germ cell tumours: expression of γ-glutamyl transpeptidase and sensitivity to cisplatin

    Previous studies have shown that the enzyme γ-glutamyl transpeptidase (GGT) is essential for the nephrotoxicity of cisplatin. This study was designed to determine whether GGT activity is necessary for the ther...

    M H Hanigan, H F Frierson Jr, V M Abeler, J Kaern… in British Journal of Cancer (1999)

    Download PDF (530 KB)

  3. Article

    HLA antigens and cervical carcinoma

    Å. HELLAND, A. L. BØRRESEN, J. KAERN, K. S. RØNNINGEN, E. THORSBY in Nature (1992)

    Download PDF (1900 KB)